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Background	
Rare	diseases	are	individually	rare	(affecting	less	than	200,000	people),	and	collectively	
affect	millions	of	people	worldwide	(Institute	of	Medicine	(US)	Committee	on	Accelerating	Rare	
Diseases	Research	and	Orphan	Product	Development	2010a;	NIH	2016;	Shen	et	al.	2015).	
Currently,	the	number	of	known,	rare	genetic	diseases	is	around	7000	and	it	is	suggested	that	as	
many	as	8000	rare	genetic	conditions	have	yet	to	be	discovered	(Dudding-Byth	et.	al,	2015;	
Lambertson,	2015).		
Over	the	last	several	years,	advances	in	technology	have	made	whole	exome	sequencing	
(WES),	a	tool	for	diagnosing	the	previously	un-diagnosable.	In	approximately	25-40%	of	patients	
tested,	WES	has	identified	the	genetic	basis	of	disease	(Sawyer,	2016).	WES	created	a	paradigm	
shift	in	how	both	healthcare	providers	and	researchers	approach	diagnosis	of	genetic	disease	
(Sawyer,	2016).		Using	WES,	researchers	have	identified	more	than	180	distinct	novel	disease-
causing	genes	(Sawyer	et	al.,	2016).	However,	rare	variants	within	these	genes	are	often	labeled	
a	“variant	of	uncertain	significance	(VUS)”	due	to	insufficient	data	available	to	determine	their	
effects	on	gene	function	and	association	with	the	patient’s	phenotype.	To	determine	causality,	
functional	studies	can	be	performed,	however	these	are	expensive,	fall	outside	the	scope	of	
clinical	diagnostics	laboratories,	and	are	rarely	covered	by	insurance.	Identifying	a	second	
unrelated	patient	with	overlapping	phenotypic	characteristics	and	the	same	variant	can	help	link	
a	variant	to	a	disorder,	but	there	is	currently	no	established	protocol	for	using	databases	to	
establish	causality	for	these	ultra	rare	diseases	(Dixon-Salazar,	2012).	
Due	to	the	increasing	use	of	whole	exome	sequencing,	more	individuals	are	now	being	
diagnosed	with	extremely	rare	conditions	not	previously	reported	in	the	medical	literature	
(hereafter	referred	to	as	“N-of-1”	disorders)	(Sawyer	et	al.,	2016).		N-of-1	diseases	tend	to	be	
severe,	life-threatening,	debilitating,	and	affect	multiple	organ	systems.	Patients	often	present	
with	multiple	problems	that	may	seem	unrelated,	and	unfortunately,	for	such	rare	diseases	little	
is	known	about	the	natural	history	of	the	disease,	and	there	are	often	no	treatment	or	medical	
management	guidelines	(Dudding-Byth	et.	al,	2015).	They	can	impair	physical,	mental,	and/or	
behavioral	capacities,	and	reduce	one’s	life	expectancy	(Schieppati,	2008).	For	N-of-1	disorders,	
the	variants	and	genes	identified	are	by	definition	novel	and	unfamiliar,	and	may	not	allow	
access	to	scientific	and	medical	expertise	(Hennekam,	2011;	Dudding-Byth	et.	al,	2015).	Ultra-
rare	diseases,	in	general,	lack	management	guidelines	and	information	on	natural	history	and	
prognosis	(Dudding-Byth	et	al.	2015).	More	than	95	percent	of	rare	diseases	lack	a	specific	
treatment	(Miyamoto	and	Kakkis	2011).	However,	a	diagnosis	validates	the	patients’	
symptomatology,	provides	information	about	prognosis	and	may	offer	hope	for	the	direction	of	
medical	care	in	the	future	(Dudding-Byth,	2015;	Krabbenborg	et	al.,	2016).	
The	benefit	of	receiving	a	diagnosis	extends	beyond	receiving	specialized	treatment.		It	
also	affords	families	the	ability	to	understand	and	label	the	condition	and	better	cope	with	the	
situation	(Senger	et	al.	2016).	A	2008	review	in	The	Journal	of	Clinical	Genetics,	describes	
patients’	adaptation	to	living	with	a	genetic	condition,	and	explores	the	process	of	coming	to	
terms	with	the	implications	of	a	health	threat,	that	“a	diagnosis	is	initially	disruptive	and	leaves	
parents	or	an	individual	feeling	out	of	control.	They	seek	ways	to	regain	feelings	of	control	by	
learning	as	much	they	can	about	the	condition,	taking	control	over	aspects	of	medical	care.”	
(Biesecker	et	al.,	2008).	The	emotional,	medical,	and	psychosocial	impact	of	rare	diseases	on	the	
patient	and	their	caregivers	is	compounded	for	those	with	N-of-1	disorders;	parents	become	the	
real	experts	of	these	ultra-rare	disorders	and	related	therapies	(Schaffer	et	al.	2008;	Budych	et	
al.	2012).		Due	to	the	low	prevalence	of	each	individual	rare	disease,	parents	of	children	with	
rare	diseases	report	having	high	stress	and	emotional	demands	related	to	feelings	of	
incompetence	and	social	isolation	(Dellve	et	al.	2006).	The	“surrounding	psychological	desert”	is	
distressing	for	N-of-1	individuals	and	their	families,	who	cite	a	lack	of	support,	even	once	they	
had	received	a	diagnosis	(Anderson	et	al.	2013;	EURODIS	2009).	Families	impacted	by	a	rare	
disease	experience	more	psychosocial	stressors	than	those	affected	by	comparable,	less	rare	
conditions	(Schieppati	et	al.,	2008).	The	nature	of	the	illness	can	present	overwhelming	
challenges	to	parents	who	bear	daily	responsibilities	for	managing	their	child’s	care,	while	
holding	at	bay	this	pervasive	fear	for	the	child’s	well-being,	and	experiencing	feelings	of	guilt	
and	personal	failure	(Senger	et	al.	2016).	Furthermore,	parents	of	children	with	complex	medical	
conditions	often	carry	extraordinary	burdens,	both	visible	and	invisible,	associated	with	care.	
Senger	et	al.	describes	how	parents	are	called	to	advocate	for	their	child	while	navigating	a	
complex	health	care	system,	“The	visible	demands	of	caring	for	a	chronically	ill	child	[…]	include	
the	technical	day-to-day	aspects	of	in-home	medical	care,	sophisticated	clinical	judgment,	and	
vigilant	monitoring	of	symptoms.	The	invisible	demands	[…]	include	worry	and	fear	about	the	
unpredictable	nature	of	the	illness	trajectory,	public	reaction	to	the	child’s	disability,	and	
wondering	how	their	child	will	fit	into	the	world,	gain	acceptance,	and	make	friends.”	(2016).		
In	the	literature,	a	frequent	theme	described	by	parents	as	being	essential	was	meeting	
other	families	with	children	diagnosed	with	similar	conditions,	and	gaining	a	sense	of	control	
over	an	uncontrollable	situation.	Patients	and	caregivers	tend	to	seek	social	support	by	joining	
support	groups,	striving	to	find	ways	to	meet	their	own	or	their	child’s	needs,	which	ultimately	
has	been	shown	to	be	associated	with	positive	adaptation	across	a	variety	of	chronic	conditions	
(Biesecker	et	al.	2008).	A	2016	NPR	article,	“Families	Isolated	by	Rare	Genetic	Conditions	Find	
New	Ways	to	Reach	Out,”	centered	on	families	affected	by	a	rare	genetic	disease,	and	how	they	
find	ways	to	search	for	others	with	their	same	condition.	The	article	explored	families’	sense	of	
isolation;	they	described	how	having	a	child	with	an	illness	that	is	likely	genetically	based,	yet	
never	before	described	in	the	scientific	literature,	landed	them	in	“an	information	desert.”	They	
explained	how	research	protocols	tend	to	keep	scientific	findings	quiet	until	they	are	published,	
or	how	health	privacy	laws	prevent	a	genetics	lab	from	connecting	two	families	who	have	the	
same	mutation.	One	parent	noted,	“These	days	there	are	ribbons	and	awareness	weeks	for	so	
many	diseases,	[…]	but	when	yours	is	ultra-rare,	you	feel	completely	isolated.	You	feel	like	
you're	never	going	to	hear	another	person	say,	'Us,	too!'	And	being	connected	to	other	families	
changes	all	that."	(Snow,	2016).	A	recent	2016	study	in	the	Journal	of	Genetic	Counseling,	
examined	the	need	for	families	to	connect	to	other	families	with	the	same	diagnosis,	through	
the	use	of	Facebook,	social	media,	and	other	forms	of	online	community	support.	One	parent	
stated,	“The	information	we	have	been	able	to	get	has	been	through	other	families	[…]	We	even	
had	[an]	awareness	day	earlier	this	month	[…]	We	are	able	to	meet	people	that	were	50	years	
old	and	that	are	diagnosed	with	[X]	syndrome.	You	know,	it	is	such	a	wonderful	thing	to	be	able	
to	see	sort	of	the	future	or	the	possibilities	of	the	future.”	(Rosell	et	al.	2016).	The	supports	that	
would	normally	be	provided	by	disease	communities,	which	aim	at	gathering	and	disseminating	
the	limited	existing	information	on	their	disease,	and	connecting	patients	and	families,	do	not	
exist	or	are	not	geared	towards	an	N-of-1	diagnosis.	For	all	these	reasons,	significant	gaps	exist	
for	N-of-1	families.		
Existing	literature	on	rare	diseases	is	highly	disease	oriented	and	technical,	primarily	
originating	from	the	research	of	medical	specialists.	Rare	disease	patients	believe	the	
information	they	receive	from	health	professionals	at	the	time	of	diagnosis	is	insufficient,	thus	
motivating	their	engagement	in	online	research	(Gundersen	2011).	Parents	use	of	the	Internet	
to	search	for	information,	and	engagement	in	online	communities	are	important	ways	parents	
often	manage	uncertainty	and	stress	regarding	their	child’s	health	condition	(Oprescu	et	al.	
2013).	It	is	estimated	that	56.3	million	people	in	the	US	use	the	internet	to	search	for	
information	about	chronic	diseases,	and	this	information	affects	their	decision-making	regarding	
their	health	(Dutta-Bergman	2004;	Rainie	et	al.	2003).	Approximately	79	million	Americans	are	
members	of	online	support	groups,	with	an	estimated	1	in	4	people	who	join	discussion	groups	
while	searching	for	disease	information	(Levy	and	Strombeck	2002;	Rainie	2005).	Individuals	
benefit	from	online	health	communities	by	receiving	informational	and	emotional	support,	and	
many	find	the	opportunity	to	share	their	own	experiences	and	provide	support	to	others	
rewarding	as	well.	Cyber-based	health	forums	allow	families	within	a	disease	community	to	help	
one	another	identify	specialists	whose	research	is	dedicated	to	a	specific	condition,	and	who	
may	be	willing	to	read	an	e-mail,	give	an	opinion,	or	even	possibly	make	an	appointment	for	a	
consult	(Eby,	2015).	Patients	who	feel	empowered	have	been	shown	to	be	more	capable	and	
effective	at	managing	their	health	conditions,	accessing	care,	and	communicating	with	
healthcare	professionals	(van	Uden-Kraan	et	al.	2009).	Online	support	communities	offer	several	
other	advantages	including	lack	of	geographic	restrictions,	24/7	availability,	and	a	degree	of	
anonymity	(Oprescu	et	al.	2013a).	Ultimately,	there	are	few	studies	examining	the	impact	of	
Internet	support	groups	in	the	rare	disease	population,	and	even	fewer	catering	to	N-of-1	
individuals	specifically,	thus	highlighting	the	need	for	further	research.	
The	goal	of	our	project	was	to	create	a	website	that	could	be	offered	as	a	resource	to	
individuals	and	families	within	the	N-of-1	disease	community.	This	resource	would	include	user-
friendly	how-to	guides	that	would	help	families	navigate	existing	genetic	databases	and	provide	
tools	to	advocate	for	themselves	through	social	media	campaigns.	In	constructing	this	website,	
we	hoped	to	provide	individuals	with	an	N-of-1	diagnosis	assistance	in	finding	others	in	similar	
situations	and	establishing	support	communities.	
Our	Process	
	 We	believed	it	was	important	to	provide	families	with	a	central	resource	that	
aggregated	all	existing	resources.	These	families	are	often	managing	difficult	lifestyles,	balancing	
busy	schedules	and	family	members’	healthcare,	and	may	not	have	the	time	to	sort	through	
resources,	or	know	where	to	start.	In	order	to	make	our	website	as	useful	and	accessible	as	
possible	for	visitors,	we	identified	the	ways	in	which	individuals	with	a	genetic	disease	and	their	
families	use	the	internet	for	information	and	support.	We	began	by	reviewing	online	resources	
currently	available,	and	collectively	assessed	the	benefits	and	limitations	specific	to	the	N-of-1	
community	for	each	resource.	Many	resources	were	found	through	Google	searches,	prior	
knowledge	of	resources	through	working	with	other	genetic	professionals,	or	previously	
successful	support	community	initiatives	by	N-of-1	individuals	and	their	families.	Based	on	this	
analysis,	we	identified	which	websites	to	include	and	among	those,	which	required	step-by-step	
instructions.	Primarily,	these	resources	permitted	individuals	and	their	families	to	share	their	
information	online	through	various	social	media	platforms	or	online	databases	that	matched	
individuals	based	on	their	genetic	information.	For	each	resource	that	allowed	individuals	with	
an	N-of-1	diagnosis	to	connect	with	others	based	on	genotype	or	phenotype	we	created	a	how-
to	guide.	Our	goal	was	to	provide	a	wide	range	of	options	to	increase	the	chance	of	successfully	
connecting	individuals	or	families.	
There	is	a	direct	relationship	between	active	participation	on	social	media	and	the	
likelihood	of	making	useful	connections	(Baruah,	2012).	How-to	guides	for	Facebook,	Twitter,	
Wordpress,	Reddit,	and	Wikipedia	were	all	chosen	to	allow	members	with	an	N-of-1	diagnosis	to	
create	their	own	social	media	campaigns	and	empower	them	to	tell	their	own	story.	We	
reasoned	that	these	how-to	guides	are	good	starting	points	for	N-of-1	individuals	since	most	are	
already	registered	users	of	one	or	more.	For	individuals	that	currently	do	not	use	any	social	
media	the	how-to	guides	aid	them	in	setting	up	a	profile	on	various	social	media	platforms,	
begin	potential	promotion,	and	community	building.		
Another	category	of	resources	are	databases	that	allow	individuals	or	family	members	
to	enter	specific	genetic	and/or	clinical	information,	hopefully	matching	them	with	others	from	
around	the	world.	Since	N-of-1	diagnoses	are	so	incredibly	rare,	it	is	important	to	expand	
searches	beyond	a	local	geographical	region.	By	participating	in	large-scale	databases	like	
MyGene2,	GenomeConnect,	and	Undiagnosed	Diseases	Network,	these	individuals	have	the	
opportunity	to	be	matched	with	someone	from	anywhere	in	the	world.	While	these	websites	
and	databases	can	be	useful	for	finding	N-of-1	individuals,	they	are	also	difficult	to	navigate.	
They	require	a	baseline	understanding	and	ability	to	describe	the	condition,	and	genetic	
information	that	often	requires	the	assistance	of	medical	professionals	and	laboratories.	We	
provide	assistance	through	our	how-to	guides	in	making	these	resources	accessible	to	N-of-1	
families.		
The	last	group	of	how-to	guides	included	were	online	resources	that	could	be	used	by	
the	N-of-1	community	to	better	understand	their	condition,	and	to	keep	up	to	date	on	any	
scientific	research	following	a	diagnosis.	Many	of	these	are	potentially	useful,	but	require	
scientific	literacy	and	knowledge	of	specific	nomenclature	that	could	present	an	obstacle	for	
many	families	or	individuals.	Therefore,	we	created	how-to	guides	to	be	used	as	companion	
resources	to	Google	Alerts,	Human	Phenotype	Ontology	(HPO)	and	PubMed.		
Simplicity	was	key	in	the	creation	of	the	how-to	guides,	while	still	clearly	describing	a	
complicated	process.	How-to	guides	required	multiple	screenshots	illustrating	the	step-by-step	
process	one	would	take	when	navigating	the	resources.	We	wanted	to	ensure	that	the	guides	
were	easy	to	follow.	This	was	done	by	including	red	arrows,	boxes,	and	text	boxes	on	the	
pictures	so	users	would	know	exactly	where	to	look	to	find	the	information	required	to	move	
forward.	Each	guide	was	initially	made	by	one	group	member,	followed	by	multiple	rounds	of	
edits	by	other	group	members	and	advisors.	An	example	how-to	guide	can	be	seen	in	Appendix	
A.	
Additionally,	we	provided	brief	resource	summaries	for	SWAN,	PEER,	Global	Genes,	Rare	
Disease	Day,	ClinVar,	ClinGen,	OMIM,	Genetic	Alliance	and	NORD.	We	believe	it	was	useful	to	
bring	an	awareness	to	these	resources	for	the	N-of-1	community,	but	also	recognized	they	were	
primarily	geared	toward	other,	more	“traditional”	rare	disease	audiences,	healthcare	
professionals,	researchers,	and	clinical	laboratories.	While	our	primary	goal	was	to	focus	on	
resources	that	would	help	connect	N-of-1	families	to	each	other,	we	also	wanted	to	put	other	
carefully	selected,	relevant	educational	and	informative	resources	in	one	place.	We	also	
provided	an	external	link	to	the	NIH’s	genome.gov,	a	web-based	tool	that	provides	a	thorough	
and	detailed	genetics	glossary.	We	felt	it	could	be	beneficial	for	individuals	in	the	N-of-1	
community	to	strengthen	their	understanding	about	genetics.	
													When	naming	the	website	and	identifying	potential	branding	opportunities,	we	wanted	
to	find	something	that	would	encompass	the	uniqueness	of	individuals	in	the	N-of-1	community.	
We	also	wanted	a	name	that	could	become	a	symbol	for	the	community	as	a	whole.	While	
researching	available	resources,	we	read	many	patient	stories	to	better	understand	what	some	
of	these	individuals	and	their	families	experience.	The	unicorn	embodies	the	hopeful	thought	
that	even	though	you	have	not	met	someone	with	your	disease,	it	does	not	mean	they	do	not	
exist.	It	is	also	a	symbol	that	equates	rareness	with	something	special	and	beautiful,	rather	than	
isolation	and	bad	luck.	
														Once	we	established	a	name	and	logo	for	the	website,	DNA	unicorn,	we	researched	
potential	website	domains.	Our	top	priorities	when	choosing	a	website	builder	was	ease	of	use	
and	price	point.	Potential	website	builders	we	evaluated	were	Squarespace,	Wix,	Weebly,	
Wordpress,	and	eHost.		We	chose	Squarespace	because	it	was	relatively	user-friendly,	and	
provided	video	tutorials,	as	well	as	additional	links	to	help	navigate	the	system.	Squarespace	
provided	dozens	of	templates	to	choose	from,	thus	enabling	us	to	customize	the	website	to	our	
needs.	These	customizable	templates	provide	a	certain	level	of	control,	and	come	with	built-in	
integrations,	so	that	adding	plug-ins,	links,	and	files	like	PDFs,	can	be	done	directly	on	the	
website.	Our	focus	when	picking	a	template	was	to	choose	one	that	allowed	us	to	upload	
multiple	PDFs	into	one	page	while	still	being	able	to	organize	them	neatly	in	an	order	we	felt	
most	desirable.	Squarespace	also	offers	free	unlimited	hosting,	meaning	there	is	no	limit	to	the	
site's	storage	and	bandwidth.	This	was	important	for	any	potential	future	growth	of	DNA	
Unicorn.	Lastly,	of	the	many	domains	we	researched,	Squarespace	was	one	of	the	most	
affordable,	providing	a	student	discount	with	a	two-year	subscription.	
Upon	completion	of	the	website,	a	beta	version	was	sent	to	fourteen	genetics	
healthcare	professionals	for	their	feedback.	We	received	feedback	through	a	seven-question	
survey.	We	asked	participants	to	evaluate	the	aesthetics,	language	and	content	of	the	website,	
and	of	the	specific	how-to	guides.	Based	on	the	feedback	that	we	received,	we	incorporated	
appropriate	changes	to	the	website.		
Below	we	will	discuss	each	resource	that	is	featured	on	our	website,	their	purpose,	
strengths,	limitations,	and	utility	within	the	N-of-1	community.		
Matchmakers	
MyGene2:	https://www.mygene2.org/MyGene2/		
MyGene2	is	a	patient	portal	designed	to	assist	families	in	finding	a	community	of	those	
with	the	same	rare	disease	diagnosis.	MyGene2	can	be	accessed	by	families,	clinicians,	and	
researchers	to	input	medical	and	genetic	information	that	can	be	shared	with	others.	Families	
and	the	MyGene2	matching	system	can	search	up	to	date	profiles	to	look	for	matches	based	on	
phenotype,	gene	mutation,	or	ideally	both.	Furthermore,	MyGene2	is	linked	to	Match	Maker	
Exchange	(MME).	MME	is	a	large	patient	database	that	increases	the	chance	of	finding	a	match	
since	it	searches	through	a	larger	pool	of	affected	individuals.	
Because	both	families	and	healthcare	professionals	can	access	MyGene2,	it	can	be	a	
good	place	for	a	variant	or	candidate	genes	to	be	confirmed	as	the	cause	of	a	condition.	If	
MyGene2	matches	families	with	the	same	candidate	gene	or	overlapping	clinical	characteristics,	
researchers	who	access	the	database	can	interpret	the	pathogenicity	and	causality	of	that	
particular	gene	or	variant,	and	subsequently	study	possible	genotype-phenotype	correlations.	
Confirmation	of	a	diagnosis	allows	healthcare	professionals	to	provide	more	appropriate	
expectations	and	medical	management,	thus	informing	and	assisting	families’	medical	care	and	
decision-making.	
While	MyGene2	is	relatively	easy	to	navigate	for	N-of-1	families,	problems	can	arise	
when	submitting	genetic	information.	MyGene2’s	application	form	and	instructions	use	
scientific	language	that	may	be	challenging	for	families	to	understand.	Because	of	the	complex	
nature	of	the	genetic	test	results,	and	the	language	used	on	MyGene2’s	application,	there	is	
room	for	error	or	misinterpretation	when	submitting	the	information.	This	poses	a	problem,	as	
the	matches	rely	on	the	accuracy	of	the	genetic	information	provided.	To	ensure	the	
information	entered	matches	both	their	genetic	test	results	and	clinical	picture,	and	thus	
assuring	an	appropriate	match,	families	may	need	to	seek	the	assistance	of	their	healthcare	
provider	
The	Undiagnosed	Diseases	Network:	https://undiagnosed.hms.harvard.edu/	
The	Undiagnosed	Diseases	Network	(UDN)	is	targeted	to	those	individuals	who	have	yet	
to	receive	a	genetic	diagnosis	explaining	the	cause	of	the	symptoms	they	experience.	This	
patient	population	is	affected	with	disorders	that	have	not	been	diagnosed	using	conventional	
genetic	testing	methods.		
The	UDN’s	goal	is	to	encourage	collaboration	between	clinical	and	research	experts	at	
top	institutions	across	the	United	States,	and	to	solve	challenging	undiagnosed	cases	that	
burden	individuals	and	families.	The	UDN	aims	is	to	help	individuals	and	their	families	
understand	the	nature	of	their	disease	and	to	connect	with	others	who	are	similarly	affected.	
When	submitting	an	application,	the	UDN	system	is	simple	to	navigate	for	families	
without	a	science	or	medical	background.	Additionally,	the	UDN	provides	great	resources	that	
outline	topics	including	the	genetic	testing	process,	and	how	to	find	similarly	affected	individuals	
online.	One	drawback	of	the	UDN	system	and	application	process	is	that	patients	and	their	
families	require	supporting	documentation	from	their	healthcare	provider.	Providers	must	have	
a	referral	letter	outlining	previously	completed	testing	and	a	summary	of	the	patient’s	
symptoms.	While	this	ensures	a	higher	percentage	of	applications	are	appropriate	for	the	
overarching	goal	of	the	UDN’s	mission,	it	can	be	a	barrier	for	families	who	wish	to	enrol	but	
whose	providers	did	not	submit	the	required	information.			
As	more	individuals	are	completing	applications	and	being	accepted	into	the	network,	
there	is	an	ever-growing	list	of	candidate	genes	being	discovered.	While	the	main	goal	of	the	
study	is	to	increase	understanding	about	the	genetic	contribution	to	human	disease,	the	UDN	
makes	an	effort	to	support	families	following	a	diagnosis.	UDN	recognizes	that	having	a	rare	
diagnosis	is	isolating	and	taxing	on	families,	and	works	to	combat	that	through	social	media	
exposure	(Dellve	et	al.	2006).	Once	a	diagnosis	is	confirmed,	UDN	will	assist	families	in	creating	a	
profile	that	will	outline	their	symptoms,	diagnosis,	and	personal	stories.	Families	are	consulted	
about	how	much	or	how	little	information	they	are	comfortable	sharing	and	once	completed	by	
the	UDN,	that	profile	can	be	shared	on	their	website	and	various	social	media	platforms	(i.e.	
Reddit,	Facebook,	and	Twitter).	The	profiles	created	by	the	UDN	are	similar	to	ones	we	have	
outlined	in	DNA	Unicorn	through	how-to	guides.	The	limitation	of	social	media	campaigning	
through	UDN’s	platforms	is	that	they	can	only	be	discovered	when	looking	at	the	UDN	website	
or	social	media	pages.					
GenomeConnect:	https://www.genomeconnect.org/	
GenomeConnect	is	an	online	registry	and	database	that	allows	users	to	securely	and	
confidentially	share	their	health	data	and	genetic	test	results.	By	sharing	information	through	
GenomeConnect,	users	add	to	the	knowledge	base	of	genetics,	health,	and	the	relationship	
between	the	two	domains.	This	knowledge	assists	physicians	and	researchers	in	understanding	
the	genetic	basis	of	certain	diseases	and	aids	in	the	development	of	treatments.	
GenomeConnect	now	has	a	Participant	Matching	System	that	users	can	opt	to	join.	The	
Participant	Matching	System	helps	users	connect	and	find	others	with	a	similar	diagnosis.	
GenomeConnect	is	open	to	all	adults	(18	or	older)	and	users	must	meet	one	of	the	following	
criteria:	have	already	had	genetic	testing,	are	considering	genetic	testing,	or	are	family	members	
of	someone	who	has	had	genetic	testing.	This	resource,	alongside	MyGene2,	is	one	of	few	that	
exist	for	the	purpose	of	matching	users	based	on	genetic	and	phenotypic	data	using	a	secure	
portal.	It	can	be	time-consuming	for	users	to	enter	phenotypic	data,	especially	if	multiple	organ	
systems	are	involved,	but	this	is	necessary	in	order	to	best	match	with	others.	
The	Participant	Matching	System	is	a	new	part	of	the	GenomeConnect	resource,	which	
means	that	at	this	time	the	number	of	enrolled	users	is	likely	still	relatively	small.	Additionally,	
because	this	is	a	newer	feature	of	GenomeConnect,	fewer	health	care	providers	are	aware	that	
it	exists	and	may	not	be	directing	their	N-of-1	patients	to	the	website.	The	more	people	
participate,	the	more	the	database	will	grow,	increasing	the	number	of	matches.	This	resource	
appears	to	only	be	available	in	English,	so	users	around	the	world	may	have	difficulty	accessing	
GenomeConnect.	It	will	be	important	to	engage	users	around	the	world,	especially	with	N-of-1	
diseases	because	of	the	extreme	rarity	of	each	individual	disease.	
PEER:	http://www.geneticalliance.org/programs/biotrust/peer	
Platform	for	Engaging	Everyone	Responsibly	(PEER)	is	an	online	platform	offered	
through	the	Genetic	Alliance	that	allows	people	to	electronically	share	their	health	data	for	
research.	Anyone,	regardless	of	his	or	her	current	health,	can	register	and	enter	health	data.	
Physicians	and	researchers	also	register	to	be	a	part	of	PEER	and	create	profiles	so	that	
participants	understand	their	areas	of	research	and	practice.	Participants	can	decide	which	
researchers,	physicians,	and	organizations	are	allowed	to	access	their	contact	information	and	
data,	and	what	specific	data	they	can	have	access	to.	Participants	are	able	to	change	their	access	
settings	at	any	time.	Different	disease	advocacy	organizations	can	create	their	own	portal	and	
community	within	PEER.	Participants	can	register	for	PEER	through	an	existing	disease	
organization	portal	or	as	an	individual	independent	from	an	advocacy	organization.	PEER	can	be	
used	by	participants	to	connect	with	researchers	and	physicians	who	have	research	interest	in	a	
specific	gene	or	type	of	disease	and	help	add	to	their	knowledge	base.	Through	PEER	
participants	may	also	find	a	clinical	trial	or	physicians	that	have	expertise	in	treating	a	specific	
type	of	disease.	PEER	has	community-based	examples	to	help	users	decide	what	information	to	
share.	The	community-based	examples	are	guides	developed	by	PEER	users	affiliated	with	
specific	disease	advocacy	organizations	to	help	people	choose	their	privacy	settings.	At	this	
point	PEER	only	has	around	45	disease-specific	communities.	N-of-1	families	would	have	to	sign	
up	as	an	individual,	a	feature	that	currently	offers	less	guidance	on	registering	and	selecting	
privacy	settings.	While	PEER	has	the	potential	to	be	an	excellent	resource	for	many	N-of-1	
families,	it	is	currently	being	updated	and	the	link	to	register	for	PEER	as	an	individual	is	
currently	unavailable.	
Social	Media	
Social	media	is	a	type	of	electronic	communication	using	websites	and	applications	that	
allow	users	to	create	and	share	content,	and	to	network	with	others.	Social	media	websites	are	
useful	for	sharing	personal	stories	and	campaigns	across	the	world	for	free.	They	can	be	
accessed	anytime,	by	anyone	with	a	device	or	personal	computer,	and	anywhere	as	long	as	an	
Internet	connection	or	mobile	network	is	available.	The	story	of	Bertrand	Might	is	an	example	of	
how	social	media	can	be	used	successfully	to	share	a	rare	disease	story	in	order	to	identify	other	
individuals	with	the	same	gene	and	phenotype	to	create	a	rare	disease	community	(Mnookin,	
2014).	When	Matthew	and	Cristina	Might’s	son	Bertrand	was	diagnosed	with	an	N-of-1	genetic	
disease,	Matthew	wrote	a	powerful	online	essay	on	his	already	popular	blog	detailing	his	
family’s	experience	and	shared	it	on	Reddit	(Might,	2012).	Within	24	hours	the	essay	had	gone	
viral,	was	shared	on	several	social	media	websites,	and	was	the	top	story	on	Reddit	(Mnookin,	
2014).	Through	sharing	his	family’s	story,	Matthew	Might	was	able	to	find	other	individuals	
around	the	world	with	the	same	genetic	disease	as	Bertrand,	thus	creating	a	community	for	
himself	and	others.	To	help	other	families	utilize	social	media	to	effectively	find	others	with	the	
same	N-of-1	disorder,	we	created	how-to	guides	for	four	popular	social	media	websites:	
Facebook,	Twitter,	Reddit,	Wordpress	(blogs),	and	Wikipedia.	
Facebook:	https://www.facebook.com/	
As	of	July	2016,	Facebook	had	1.71	billion	monthly	active	users	worldwide	(Fiegerman,	
2016).	Anyone	with	Internet	access	and	an	email	address	or	phone	number	can	create	an	
account	on	Facebook,	although	there	are	minimum	age	restrictions	in	some	locations.	Users	can	
send	“friend”	requests	to	other	users,	which	allows	them	to	see	each	other’s	posted	content.	
Registered	users	are	able	to	post	text,	pictures	and	videos,	files,	privately	message	others,	and	
join	private	or	public	interest	groups.	The	ability	of	anyone	to	create	a	group	is	especially	useful	
for	N-of-1	families	because	they	can	use	this	function	to	create	their	own	support	communities.	
The	person	who	creates	a	group	has	the	ability	to	decide	who	can	join	and	what	content	is	
shared	within	the	group.	Also,	there	are	privacy	settings	that	can	be	adjusted	to	allow	only	
group	members	to	see	the	content	shared	on	the	group	timeline.	This	is	particularly	useful	when	
discussing	personal	health	information	or	posting	photos	of	minors.	
Facebook	has	a	help	center	that	explains	its	many	features	and	applications	in	a	simple	
way.	It	is	easy	to	set	up	a	personal	account	and	a	group	in	minutes.	As	with	most	social	media,	
some	individuals	may	post	controversial	and	offensive	content.	A	Facebook	user	does	have	the	
ability	to	report	offensive	content	and	block	those	individuals	who	post	it.	Another	limitation	is	
that	messages	are	only	seen	by	friends	unless	they	are	shared.	If	a	user	does	not	have	very	many	
active	Facebook	friends	their	message	may	not	make	it	very	far.	A	Facebook	post	can	be	made	
“public”	allowing	any	Facebook	user	to	see	it,	which	could	help	individuals	reach	a	wider	
audience.	
Twitter:	https://twitter.com/?lang=en	
Twitter	is	a	social	media	platform	where	users	post	content,	called	“tweets,”	to	their	
timelines.	Tweets	are	limited	to	140	characters	and	can	be	linked	to	articles	and	videos.	Users	
can	follow	others	and	be	followed,	and	you	are	able	to	view	many	accounts	without	being	a	
registered	user.	Registered	users	can	“reply”	publicly	to	another	user’s	tweet	and	direct	private	
messaging	is	also	available	to	individuals	who	follow	each	other.	In	addition	to	social	
networking,	Twitter	can	also	be	used	to	find	out	about	current	events	and	news	from	around	
the	world.	As	of	June	2016	Twitter	had	313	million	active	users	
(https://about.twitter.com/company).	Organizations	can	also	create	Twitter	accounts	to	interact	
with	and	keep	their	followers	up	to	date	on	the	organization.	Making	a	Twitter	account	takes	
very	little	time.	For	those	who	want	it,	Twitter	allows	for	some	degree	of	anonymity	because	
sharing	personal	information	is	not	required.	On	Twitter,	users	can	search	for	topics	of	interest	
and	see	tweets	pertaining	to	a	particular	topic.	For	N-of-1	families,	Twitter	could	be	another	way	
to	share	their	stories,	to	search	for	others,	and	to	stay	updated	with	news	and	events	from	rare	
disease	organizations.	While	Twitter	is	useful	for	staying	updated	on	current	events,	Twitter	
must	be	checked	frequently,	especially	if	following	multiple	accounts	as	their	timelines	will	be	
constantly	changing.	Additionally,	a	tweet	is	limited	to	140	characters,	so	users	must	be	succinct	
and	thoughtful	about	word	choice	to	maximize	the	impact	of	a	tweet.	It	can	be	difficult	to	tweet	
about	more	detailed	or	complicated	subjects.	
Reddit:	https://www.reddit.com/	
Reddit	is	a	platform	that	allows	it’s	online	community	to	rate	and	discuss	web	content	
posted	by	its	users.	According	to	recent	Reddit	web	traffic	statistics,	as	of	November	2016,	
Reddit	had	over	100	million	monthly	visitors	(12	million	unique	users)	
(https://www.reddit.com/r/AskReddit/about/traffic/).	The	website	has	a	rating	system	that	
allows	registered	Reddit	users	to	“upvote”	or	“downvote”	content	based	on	their	opinion	of	
whether	a	post	contributes	to	the	conversation	or	not.	Per	Reddit,	“Through	voting,	users	
determine	what	posts	rise	to	the	top	of	community	pages	and,	by	extension,	the	public	home	
page	of	the	site.”	(https://reddit.zendesk.com/hc/en-us/articles/204511479-What-is-Reddit-).	
Content	ratings	will	determine	the	level	of	success	and	visibility	each	post	receives.	There	are	
discussions	and	posts	on	Reddit	that	cover	a	large	number	and	wide	range	of	subjects.	Reddit	is	
different	compared	to	other	social	media	platforms	in	that	by	voting,	the	users	have	an	active	
role	in	deciding	the	content	that	appears	at	the	top	of	each	page	(this	is	the	content	that	is	the	
most	popular).	Furthermore,	in	Reddit	users	can	participate	in	open	discussion	forums	with	
more	anonymity	than	Facebook.	With	Reddit	it	is	easier	to	have	a	discussion	about	a	particular	
topic	than	it	is	on	Twitter	because	the	user	is	not	limited	to	a	140-character	post.	Reddit	can	be	
a	good	source	for	sharing	complex	personal	stories	and	creating	a	common	interest	community.	
The	example	of	Matthew	Might	illustrates	the	power	of	Reddit	in	sharing	a	story	around	the	
world.	However,	Reddit	is	not	user	friendly	and	it	takes	a	significant	amount	of	time	to	learn	to	
use	all	of	its	features.	Additionally,	there	are	certain	parts	of	Reddit	that	are	not	accessible	
unless	the	user	has	enough	“Karma	points”,	which	are	gained	through	consistent	use	and	voting	
on	posts.	A	user	has	to	be	sufficiently	active	in	the	Reddit	community	to	gain	the	Karma	points,	
meaning	they	have	to	make	a	significant	contribution	to	the	site	before	being	able	to	access	the	
full	benefits	of	the	platform.		
Wikipedia:	https://www.wikipedia.org/	
Wikipedia	is	an	online	encyclopedia	that	is	written	by	people	individually	or	in	
collaboration.	Wikipedia	is	a	resource	that	N-of-1	families	can	utilize	to	distribute	information	
about	a	given	condition.	Individuals	can	share	educational	information	about	gene	structure	and	
function,	or	the	symptoms,	management,	and	possible	therapies	of	a	defined	disease.	The	hope	
for	N-of-1	families	is	that	a	Wikipedia	page	can	educate	people	who	search	for	the	gene	or	
disease.	Wikipedia	is	a	great	platform	for	these	families	to	start	with	as	it	is	used	on	a	global	
scale,	and	places	near	the	top	of	most	Google	or	other	search	engine	results.	
Wikipedia	does	pose	some	challenges	for	first	time	users,	specifically	regarding	the	
guidelines	for	what	is	and	isn’t	allowed.	Wikipedia	does	not	permit	users	to	create	a	Wikipedia	
page	about	themselves	for	any	personal	campaign.	Therefore,	if	users	are	affected	by	an	N-of-1	
disease	and	decide	to	create	a	Wikipedia	to	share	their	story,	they	would	be	in	violation	of	the	
websites	policies.	Affected	individuals	can	work	around	these	restrictions	by	creating	Wikipedia	
pages	about	the	gene	or	condition	they	are	affected	by.		Wikipedia	does	allow	individuals	to	
create	pages	about	other	people.	Therefore,	families	can	create	Wikipedia	pages	about	the	gene	
change	that	caused	an	affected	family	members	symptoms	and	their	journey	to	finding	a	
diagnosis	and	effective	management.			
Wikipedia	is	relatively	simple	to	use	in	its	most	basic	format.	It	is	a	resource	that	all	
families	should	be	able	to	utilize	to	promote	their	condition	in	order	to	create	an	N-of-1	
community.	When	adding	additional	features	to	the	Wikipedia	page	some	coding	is	required	
which	complicates	the	process	considerably.	Coding	is	required	to	change	the	font	or	color	of	
the	text,	as	well	as	to	insert	images,	video,	and	other	links.	These	features	are	fundamental	to	
creating	an	effective	Wikipedia	that	captures	an	audience	when	establishing	an	N-of-1	
community.	
Blogs:	https://www.wordpress.com/	
Blogs	were	created	to	allow	individuals	to	express	themselves	online	in	a	form	of	an	
online	journal.	Since	then,	blogs	have	evolved	into	a	platform	for	company	press	releases,	artist	
portfolios,	a	space	for	businesses	to	engage	their	clientele,	and	countless	other	purposes.	Using	
a	blog	to	document	one’s	life	gathers	like-minded	curious	readers.	As	blog	sites	have	developed,	
bloggers	are	able	to	establish	connections	with	their	readers	and	create	virtual	communities.	
There	are	a	myriad	of	different	blog-creating	websites	that	allow	users	to	create	blogs	that	suit	
their	needs.	Often	these	blogs	range	from	the	free	and	easy	to	use,	to	more	complicated	
versions	with	monthly	fees.	These	websites	provide	a	domain	name,	templates,	and	blog	
builders	that	allow	users	to	customize	their	blog	based	on	their	needs	and	personal	style.	
Creating	a	blog	can	be	overwhelming,	but	the	process	is	simplified	when	choosing	a	website	
builder	with	easy	to	use	templates	and	clear	instructions.	Regardless	of	the	blog	users	choose,	
there	will	always	be	some	degree	of	trial	and	error	involved	in	the	creative	process.	Our	how-to	
guide	focused	on	using	Wordpress	to	create	a	free	blog.	Despite	the	free	templates	being	
simple,	and	not	having	options	available	to	those	with	a	monthly	fee	(i.e.	removing	Wordpress	
advertising,	site	storage,	monetizing	abilities,	and	advanced	design	tools),	it	is	sufficient	for	the	
purposes	of	spreading	awareness	regarding	N-of-1	diseases	and	establishing	support	
communities.	
Once	users	have	created	their	blog,	it	needs	to	be	continually	edited	to	suit	their	
changing	needs,	as	well	as	updated	with	new	content	to	allow	readers	to	view	and	follow	their	
journey.	For	N-of-1	families,	blogs	can	be	used	to	share	their	diagnostic	odyssey,	daily	struggles,	
and	triumphs	in	order	to	form	connections	with	similarly	affected	individuals.	A	blog	can	also	be	
used	as	a	therapeutic	outlet.	Blogs	work	best	for	these	individuals	and	families	when	they	are	
open	and	forthcoming	with	personal	genetic	information	and	stories	regarding	their	diagnosis.	
The	more	information	provided,	the	more	likely	someone	will	read	it	and	correctly	identify	
themselves	as	being	similarly	affected.	Blogs	can	be	beneficial	in	that	they	allow	one’s	struggles	
to	be	heard,	but	the	ultimate	aim	of	the	blog	how-to	guides	was	to	facilitate	the	blog’s	ability	to	
build	a	community.		
Scientific	Literature	and	Databases	
PubMed:	https://www.ncbi.nlm.nih.gov/pubmed/	
PubMed	is	a	free,	searchable,	online	database	that	houses	abstracts	and	links	to	
publications	in	the	life	and	biomedical	science	literature.	While	PubMed	is	a	valuable	resource	
that	is	updated	daily	by	the	United	States	National	Library	of	Medicine	and	the	National	Institute	
of	Health.	Its	target	audience	is	healthcare	providers,	researchers,	and	those	in	academia.	
PubMed	is	more	successful	when	one	knows	what	they	are	searching	for	and	can	enter	in	search	
terms	that	yield	appropriate	results.	Success	with	PubMed	is	minimal	when	the	user	is	entering	
combinations	of	keywords	on	a	trial	and	error	basis.	For	many	N-of-1	families,	this	trial	and	error	
process	is	their	only	option.	This	is	further	complicated	by	the	fact	that	PubMed	does	not	freely	
supply	the	literature	in	its	library	to	all	users.	Many	journal	articles	come	with	a	hefty	and	
unrealistic	price	tag	for	the	average	N-of-1	family.	Those	who	remain	undiagnosed	are	able	to	
search	combinations	of	unique	clinical	identifiers	in	the	hopes	of	finding	literature	on	a	
condition	that	matches	theirs.	However,	this	approach	is	often	unsuccessful	and	time	
consuming.	For	those	who	do	receive	a	genetic	diagnosis	following	testing,	that	genetic	variant	
can	be	searched	within	PubMed,	and	the	results	may	provide	a	good	starting	place	if	families	are	
interested	in	contacting	researchers	or	following	developments	in	the	field.	The	weakness	of	
PubMed	is	that	it	does	not	cater	to	a	lay	audience,	thereby	limiting	the	use	of	its	extensive	
library	for	most	of	those	with	N-of-1	disease.	Lay	users	may	find	it	helpful	to	share	their	findings	
on	PubMed	with	their	healthcare	providers	assistance.		
Gene	Reviews	&	OMIM:	https://www.ncbi.nlm.nih.gov/books/NBK1116/	;	
https://www.omim.org/	
Gene	Reviews	and	Online	Mendelian	Inheritance	in	Man	(OMIM),	much	like	PubMed,	
are	resources	that	are	likely	to	be	challenging	to	understand	for	individuals	who	do	not	have	a	
background	in	clinical	and	molecular	genetics.	GeneReviews	is	an	international	point-of-care	
resource	tailored	to	busy	clinicians	that	provide	clinically	relevant	and	medically	actionable	
information	about	inherited	conditions.	OMIM	is	a	well-referenced	online	catalogue	of	human	
genes	and	genetic	disorders.	Both	resources	contain	an	extensive	library	of	well	documented,	
peer-reviewed,	and	up	to	date	information	on	genetic	conditions	or	genes	associated	with	
medical	conditions.	However,	by	definition,	N-of-1	genetic	conditions	are	absent	from	the	
literature	due	to	a	lack	of	any	well-documented	cases,	as	well	as	uncertainty	as	to	the	
pathogenicity	of	candidate	genes.		
Additionally,	these	resources’	target	audience	is	medical	professionals	and	researchers.	
While	Gene	Reviews	does	feature	drop-down	boxes	that	provide	simplified	definitions	for	
various	words	to	accommodate	a	lay	audience,	information	may	be	too	complicated	for	the	
average	individual.	OMIM	pulls	together	the	published	literature	and	research	regarding	on	a	
particular	condition	or	gene,	which	unfortunately	does	not	always	apply	to	N-of-1	conditions.	Of	
the	information	OMIM	does	provide,	much	of	it	would	not	be	appropriate	for	a	lay	audience.	
HPO	and	Phenomizer:	http://human-phenotype-ontology.github.io/:	
http://compbio.charite.de/phenomizer/	
The	Human	Phenotype	Ontology	(HPO)	is	a	project	in	partnership	with	the	Monarch	
Initiative	that	is	directed	at	standardizing	the	medical/scientific	terms	used	to	describe	
phenotypes	associated	with	human	disease.	The	initiative	uses	the	scientific	and	medical	
literature,	and	resources	such	as	OMIM,	DECIPHER,	and	Orphanet	to	build	the	HPO	database.	
Each	of	the	terms	in	the	HPO	describes	a	specific	phenotypic	feature,	and	is	associated	with	a	list	
of	synonyms	that	includes	the	“lay	person”	terms	commonly	used	to	describe	the	feature.	A	
definition	of	the	term	is	often	included.	The	HPO	was	designed	for	use	by	clinicians	and	
scientists;	however,	the	HPO	is	available	to	freely	use	online	and	may	be	helpful	for	N-of-1	
families	when	trying	to	determine	medical	terms	to	describe	the	affected	individual’s	
phenotypic	features.	The	HPO	has	approximately	11,000	terms	as	of	Feb.	2017	with	new	terms	
continually	being	added	(http://human-phenotype-ontology.github.io/about.html).	The	HPO	is	
difficult	to	navigate	and	use;	it	takes	a	significant	amount	of	trial	and	error	for	the	user	to	
understand	how	to	efficiently	use	it.	Additionally,	not	all	terms	in	the	HPO	have	had	a	definition	
added	to	their	respective	pages	yet.	That	being	said,	this	resource	can	be	helpful	when	entering	
data	into	matchmaking	databases	such	as	GenomeConnect	or	MyGene2	to	ensure	that	standard	
terminology	is	being	used	when	entering	phenotypic	information.	
The	Phenomizer	is	a	database	of	diseases	that	can	assist	in	the	diagnosis	of	a	disease	
based	on	phenotype.	HPO	terms	are	applied	to	the	diseases	that	are	in	the	Phenomizer	
database.	The	Phenomizer	was	designed	to	assist	physicians	in	creating	a	list	of	differential	
diagnoses	during	a	diagnostic	work	up.	Entering	the	phenotypic	features	of	a	patient	produces	a	
ranked	list	of	possible	diagnoses.	Again,	this	tool	is	freely	available	to	the	general	public	so	it	can	
be	accessed	by	anyone,	but	it	is	most	useful	for	individuals	who	are	more	scientifically	inclined.	
The	Phenomizer	may	be	used	by	individuals	and	their	families	who	are	still	searching	for	a	
definitive	diagnosis	that	explains	their	phenotype.	Like	the	HPO,	the	Phenomizer	is	difficult	to	
use	and	is	easier	to	navigate/understand	if	the	user	has	a	medical	background.	If	people	without	
a	medical	background	are	using	this	resource	they	will	likely	need	to	consult	with	a	medical	
professional	before	knowing	how	to	proceed	based	on	the	list	of	possible	diagnoses	generated	
by	the	HPO.	Additionally,	the	HPO	list	does	not	include	every	possible	diagnosis,	which	is	
important	to	keep	in	mind	when	considering	a	differential	diagnosis.	
ClinGen:	https://clinicalgenome.org/	
ClinGen	is	a	National	Institutes	of	Health	(NIH)-funded	initiative	dedicated	to	building	a	
central	resource	that	defines	the	clinical	relevance	of	genes	and	variants	for	use	in	precision	
medicine	and	research.	ClinGen	has	different	working	groups	that	focus	on	generating	and	
maintaining	the	numerous	resources,	tools,	and	registries	that	are	linked	through	the	ClinGen	
website.	The	registries	associated	with	ClinGen	(such	as	GenomeConnect,	described	previously)	
share	genomic	and	phenotypic	data	in	a	centralized	database	for	research	and	clinical	use.	
ClinGen	aims	to	standardize	how	variants	are	interpreted,	implement	evidence-based	guidelines	
and	develop	algorithms	for	variant	interpretation.	The	centralized	databases	will	also	improve	
our	understanding	of	variants	in	diverse	populations,	determine	the	clinical	validity	of	variants,	
and	give	an	indication	based	on	expert	opinion	of	whether	or	not	the	information	will	alter	
clinical	management	of	patients.	The	content	and	functionality	of	ClinGen	were	designed	to	be	
used	by	scientists	and	clinicians,	and	individuals	and	families	may	benefit	more	from	ClinGen	by	
bringing	it	up	for	discussion	with	their	providers,	rather	than	utilizing	it	on	their	own.			
ClinVar:	https://www.ncbi.nlm.nih.gov/clinvar/	
ClinVar	is	a	NIH-funded	project	that	is	partnered	with	ClinGen.	ClinVar	is	a	database	that	
archives	information	on	genomic	variants	and	reports	on	their	interaction	with	human	health.	
Clinical	laboratories,	expert	panels,	professional	societies,	and	researchers	submit	variants	to	
ClinVar	and	rate	each	one	on	a	scale	of	benign	to	pathogenic	based	on	their	own	observations	
and	ranking	system.	ClinGen	uses	ClinVar	as	a	source	of	variant	data.	ClinGen	expert	panels	
review	the	variant	data	and	submit	standardized	interpretations	to	ClinVar	that	provide	
estimates	of	pathogenicity	that	also	indicate	a	confidence	level	for	the	call.	ClinVar	provides	a	
conflict	report	of	any	differences	in	interpretation	between	their	submitted	variants	and	those	
already	in	the	database.	ClinVar	thus	facilitates	communication	about	the	relationships	reported	
between	genomic	variation	and	observed	health	status/pathogenicity.	ClinVar	is	free	to	the	
public.	If	an	individual	has	a	variant	identified	by	genetic	testing,	they	can	search	for	the	variant	
in	ClinVar.	If	the	variant	is	there,	individuals	can	read	more	about	its	interpretation.	ClinVar	is	a	
resource	individuals	can	consult	when	trying	to	determine	the	pathogenicity	of	a	variant,	
however,	the	user	must	be	able	to	understand	the	ranking	system	for	both	the	variant	and	the	
levels	of	evidence.	In	addition,	ClinVar	can	be	confusing	to	use	because	sometimes	there	are	
multiple	pages	for	the	same	variant;	the	nomenclature	must	be	exact,	so	there	is	no	room	for	
error	when	entering	the	variant	you	are	searching	for.	
Patient	Advocacy	Organizations	
SWAN:	http://swanusa.org/	
Syndromes	Without	A	Name	(SWAN)	is	an	organization	that	offers	support	to	affected	
individuals	and	their	families	who	have	yet	to	receive	a	diagnosis.		SWAN	advocates	for	changes	
in	the	medical	community	that	will	support	individuals	who	are	undiagnosed.		This	is	a	critical	
resource	and	initiative	because	those	who	are	undiagnosed	often	lack	appropriate	treatment	
options.	This	subset	of	people	who	remain	undiagnosed	do	receive	research	dollars	that	might	
help	them	develop	better	therapies	or	management	guidelines.	SWAN	provides	great	resources	
for	families	who	are	in	this	position,	as	well	as	travel	grants	that	allow	them	to	participate	in	
research	or	testing	opportunities	they	may	not	be	able	to	afford	otherwise.	While	SWAN	is	not	
targeted	to	the	N-of-1	community,	it	still	is	a	resource	that	families	may	find	useful	and	easy	to	
understand.	
GlobalGenes:	https://globalgenes.org/	
GlobalGenes	is	a	non-profit	rare	disease	patient	advocacy	and	support	organization	that	
was	started	in	2009.	GlobalGenes	aims	to	reduce	the	challenges	of	rare	diseases	for	people	
around	the	world	by	giving	the	rare	disease	community	a	unified	voice.	They	provide	resources	
to	help	educate	and	create	awareness	of	rare	diseases.	Their	resources	are	designed	to	
empower	rare	disease	patients	and	their	families	to	become	self-advocates.	Over	500	global	
organizations	are	affiliated	with	GlobalGenes.	GlobalGenes	provides	toolkits	for	families	that	
cover	a	wide	variety	of	topics,	from	how	parents	can	advocate	for	their	children	with	a	rare	
disease	in	the	school	system	to	a	toolkit	specifically	for	people	who	have	not	yet	been	
diagnosed.	The	organization	also	provides	webinars,	documentaries,	information	on	drug	
development,	fundraising	campaigns,	and	a	patient	impact	grants.	The	information	provided	
that	promote	self-advocacy	is	especially	important	and	useful	because	it	applies	to	all	rare	
diseases.	GlobalGenes	does	not	have	information	that	is	specifically	targeted	at	N-of-1	rare	
diseases	and	thus	does	not	specifically	address	the	very	unique	challenges	that	these	individuals	
and	their	families	face.	
Other	
Google	Alerts:	https://www.google.com/alerts	
Google	Alerts	is	a	notification	service	that	provides	alerts	whenever	a	given	topic	is	
mentioned	on	the	internet.	The	goals	is	to	keep	its	users	informed	on	new	material	as	it	is	
published.	Google	Alerts	allows	users	to	create	searches	for	any	keyword(s),	tailor	the	results	
based	on	the	source	of	the	publication,	and	indicate	how	filtered	the	results	will	be.	Google	
Alerts	searches	through	blogs,	news	outlets,	websites,	videos,	books,	and	forums.	Users	can	
modify	their	alerts	to	search	through	one	publication	source,	or	a	combination	of	multiple	
sources.	Alternatively,	users	can	choose	“Automatic”	which	allows	Google	to	curate	results	
based	on	what	they	think	is	most	relevant	to	their	needs.	Results	can	also	be	filtered	based	on	
region	of	publication,	language,	and	frequency	of	alerts.	
Google	Alerts	can	be	utilized	by	anyone,	and	is	particularly	useful	for	N-of-1	families.	
Having	a	family	member	affected	by	a	rare	disease	can	be	burdensome,	and	taking	the	time	to	
search	the	internet	for	useful	or	relevant	resources	is	not	always	realistic.	Google	Alerts	
eliminates	the	time	individuals	and	their	families	would	have	spent	sifting	through	news	stories,	
trying	to	stay	up	to	date	on	new	developments.	While	Google	Alerts	can	be	very	useful,	users	
can	quickly	become	overrun	with	excess	information	and	an	overwhelming	number	of	emails.	
Modifying	the	search	options	is	critical.	To	avoid	this,	the	frequency	and	quality	of	alerts	should	
be	set	to	ensure	that	emails	are	being	received	in	manageable	intervals,	and	that	they	contain	
only	the	best	results.	Unique	identifiers	related	to	an	individual’s	disease	are	encouraged	as	
keywords	when	curating	one’s	search	options.	This	could	include	genetic	testing	results	(either	
the	gene	or	the	gene	and	variant)	or	distinctive	symptoms.	Ultimately,	Google	Alerts	is	only	as	
useful	as	the	information	available,	and	the	effort	put	forth	by	the	user.		
	
Discussion	
Limitations	
We	created	and	designed	our	website	to	be	both	a	user-friendly	and	comprehensive	
resource	that	N-of-1	families	can	utilize.	We	recognize,	however,	there	are	many	limitations	to	
this	process	and	to	our	final	product.	There	is	a	lack	of	research	on	the	specific	needs	of	N-of-1	
families	and,	without	further	evaluation,	we	cannot	be	confident	that	we	have	addressed	those	
needs	sufficiently.	Our	survey	of	genetic	healthcare	professionals	specifically	asked	for	
constructive	criticism	regarding	specific	changes	each	respondent	would	make	to	the	website.	
These	survey	questions	were	not	formatted	in	a	way	that	would	give	a	balanced	representation	
of	the	utility	of	the	website.	Until	we	receive	feedback	and	evaluations	from	N-of-1	families,	we	
are	not	able	to	accurately	assess	its	helpfulness	and	overall	utility.	
Currently,	we	are	not	affiliated	with	bigger	rare	disease	advocacy	organizations	that	
could	increase	traffic	to	the	website,	as	well	as	build	a	reputation	as	a	legitimate	resource.	At	
present,	we	have	no	personal	contact	with	the	N-of-1	patient	population,	hindering	our	ability	
to	promote	our	resource	with	this	population	directly.		As	four	graduate	students	in	genetics,	we	
also	lack	a	lot	of	expertise	in	web	design	and	other	related	aspects,	such	as	search	engine	
optimization.	A	final	limitation	of	our	website	is	that	it	only	caters	to	English	speaking	families,	
as	do	most	of	the	resources	we	link	to	and	promote.	
Themes	Found	in	Survey	Responses	
	 Based	on	feedback	from	our	survey	questions,	we	identified	five	common	themes.	The	
primary	themes	these	surveys	were	coded	for	were	the	website's	aesthetic,	language	used,	
resource	choices,	how-to	guide	utility,	and	the	clinical	utility	of	the	website	as	a	whole.	We	took	
the	qualitative	responses	and	coded	them	into	quantitative	figures	for	each	of	these	themes	
every	time	they	were	mentioned.	For	example,	anytime	a	respondent	mentioned	font	size,	
organization,	layout,	text	density,	and	graphics	their	response	was	coded	as	an	“aesthetic”	
theme.	When	respondents	commented	on	word	choice	that	was	either	too	sophisticated	for	the	
target	audience,	or	there	was	grammatical	suggestions,	it	was	coded	as	“language.”		When	
respondents	suggested	adding,	removing,	or	editing	current	resources	linked	on	the	website,	
their	response	was	coded		“resource	choice.”	Respondents	were	asked	to	comment	on	the	how-
to	guides’	ease	of	use	and	whether	they	felt	they	were	helpful	in	describing	each	resource:	these	
were	coded	as	“how-to	guide	utility.”	Lastly,	clinical	utility	was	coded	every	time	a	respondent	
stated	they	would	recommend	this	resource	to	a	patient	and	their	family.		
	 From	these	codes	aesthetics	and	language	were	mentioned	the	most.	Edits	made	based	
on	these	comments	included	decreasing	text	density,	increasing	font	size,	and	simplifying	
language	like	medical	terminology	used	in	the	case	example	case	story.	We	also	adjusted	the	
content	of	the	website	based	on	the	feedback	coded	as	resource	choice	and	utility	of	how-to	
guides.	We	added	NORD	and	Genetic	Alliance	as	additional	resources,	and	altered	the	
descriptions	of	PubMed	and	ClinVar.	Any	feasible	comments	were	incorporated,	while	others	
were	disregarded	based	on	limitations	set	by	the	website	building	platform	of	Squarespace	(i.e.	
banner	size,	menu	header	font	size,	layout,	and	adding	a	discussion	forum).	All	of	the	survey	
participants	responded	favourably	to	the	utility	of	the	website	as	a	whole.	When	asked	if	the	
resource	was	one	they	would	use	in	the	future,	or	recommend	to	patients	and	families,	all	of	
them	responded,	“Yes”.			
Future	Directions	
Now	that	the	website	and	how-to	guides	have	been	developed	they	need	to	be	
evaluated	for	utility	and	ease	of	use.	The	website	needs	to	be	tested	by	N-of-1	families	to	ensure	
that	the	content	is	appropriate	and	accessible	for	the	general	population.	The	how-to	guides	will	
need	to	be	revised	in	the	future	as	the	primary	resources	are	updated.	Additionally,	new	how-to	
guides	will	need	to	be	developed	as	more	resources	and	technologies,	such	as	new	matchmaker	
databases,	are	created	for	the	rare	disease	community.	We	would	like	to	eventually	feature	
stories	of	N-of-1	families	on	our	website	to	both	enhance	our	connection	with	the	target	
audience,	and	create	online	discussion	forums	on	our	website	so	that	families	can	interact	with	
others	facing	similar	situations.	
Additionally,	we	need	to	bring	awareness	to	our	website.	We	plan	to	contact	different	
rare	disease	advocacy	organizations	in	the	hopes	of	partnership	and	mutual	promotion	of	each	
other's	resources.	In	addition	to	these	essential	advocacy	connections,	serious	efforts	need	to	
be	made	in	order	to	promote	and	advertise	this	resource.	By	attending	genetics-focused	
conferences	in	the	future,	we	will	be	able	to	promote	our	website	to	genetics	professionals	so	
that	they	can	provide	this	resource	to	N-of-1	families	at	the	time	of	diagnosis.	
This	project	will	continue	to	evolve	to	fulfill	its	full	potential	and	its	ultimate	goal.	We	as	
a	group	are	excited	about	DNA	Unicorn	and	its	potential	to	help	N-of-1	families.			
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Appendix	A	
Formatting	slightly	different	on	website.		
Human	Phenotype	Ontology	Guide	
PART	I:	The	HPO	
One	resource	that	you	may	find	useful	is	the	Human	Phenotype	Ontology	or	HPO.	The	name	
alone	sounds	a	bit	daunting	doesn’t	it?	The	Human	Phenotype	Ontology	is	a	database	that	is	
trying	to	help	standardize	the	medical	terms	used	to	describe	different	phenotypes	(an	
individual’s	traits/characteristics/symptoms)	associated	with	human	diseases.		This	resource	is	
very	helpful	for	scientists	and	clinicians,	but	may	also	be	helpful	for	you.	Admittedly,	it	isn’t	the	
most	user-friendly	but	hopefully	this	guide	will	help	you	if	you	are	interested	in	giving	it	a	try.	
The	HPO	can	help	you	in	figuring	out	the	medical	terms	that	are	used	to	describe	the	features	
associated	with	your	or	your	loved	one’s	disease.	Knowing	the	correct	medical	terminology	can	
help	you	search	for	others	by	using	these	terms	and	can	also	help	others	to	find	you.		
To	get	to	the	HPO	homepage	go	to	http://human-phenotype-ontology.github.io/.	The	HPO	
homepage	is	pretty	busy	and	most	of	it	will	not	be	useful	to	you.	There	are	many	different	tools	
and	other	databases	that	use	the	HPO	that	you	may	come	across	if	you	explore	the	HPO	
website.	Most	of	these	were	designed	for	researchers	and	are	really	only	useful	for	that	
purpose.	To	get	to	where	you	can	search	the	HPO	go	to	lower	right	of	the	homepage.		
	
	
	
	
	
After	clicking	on	the	HPO	Browser	button	you	are	taken	to	this	page	where	you	can	search	the	
HPO.	You	can	type	in	the	words	that	you	would	use	to	describe	the	features	of	your	or	your	
child’s	genetic	disease.			
	
	
	
We	will	use	the	example	of	Anna	(see	our	mock	patient	story	first	for	the	full	description	of	
Anna)	to	explain	how	to	use	the	HPO	web	browser.	One	unusual	feature	of	Anna’s	condition	is	
an	extra	thumb.	If	you	type	extra	thumb	into	the	search	bar,	the	medical	terms	and/or	
descriptions	in	the	HPO	database	that	match	it	will	pop	up	in	blue	below.	In	this	case	there	was	
only	one	option	because	the	words	used	to	search	were	pretty	specific,	but	sometimes	multiple	
options	will	pop	up	depending	on	what	you	entered.	We	will	click	on	the	blue	box	to	select	the	
HPO	term/description	to	continue.		
	
	
After	selecting	a	term/description	from	the	list	of	options	in	the	blue	drop	down	menu	you	will	
be	taken	to	that	term’s	page.	Using	our	example	of	extra	thumb,	we	selected	the	only	option	
that	appeared	in	the	blue	drop	down	menu.	In	doing	this	we	are	taken	to	the	page	for	“Preaxial	
Polydactyly”.		
Scrolling	down	the	page	you	will	see	several	different	boxes,	each	with	different	information	
				
				
Let’s	do	another	sample	search.	Anna	was	described	as	having	small	teeth.	When	you	type	small	
teeth	into	the	search	bar,	several	matching	options	appear	in	the	drop	down	list.	We	selected	
the	“Small	teeth”	option	from	the	list	first	because	it	was	exactly	what	we	typed	in	and	was	the	
simplest	term/description	listed.	It	may	be	easiest	to	always	start	with	the	simplest	term	first.	
You	could	always	select	one	of	the	other	options	and	explore	the	page	for	that	term	to	see	if	it	
fits	with	what	you	are	trying	to	describe.	If	it	doesn’t	fit,	you	can	always	go	back	and	choose	
another	term	from	those	in	the	list.	
	
	
	
Clicking	on	the	“Small	teeth”	option	takes	us	to	the	page	for	Microdontia.	The	definition	fits	with	
our	description	of	Anna.	If	it	didn’t	seem	to	fit	we	would	go	back	and	select	a	different	term	
from	the	list.		
	
	
We	will	do	one	final	example	using	Anna’s	story.	Sometimes	you	will	type	in	a	term	and	no	
options	will	appear.	This	means	that	what	was	typed	in	the	search	bar	hasn’t	been	linked	to	an	
HPO	term	yet.	If	this	happens	you	could	try	using	a	different	description	or	searching	for	a	
broader	term	first.	
	
When	we	removed	the	word	“weak”	and	kept	“tooth	enamel”	options	appeared	in	the	drop	
down	list.	We	selected	Abnormal	tooth	enamel.	
	
“Abnormality	of	dental	enamel”	fits	with	what	we	are	trying	to	describe	(weak	enamel)	about	
Anna,	but	is	still	a	pretty	broad	term.	If	the	term	you	end	up	with	seems	too	broad	you	can	look	
for	more	specific	terms	by	looking	at	the	terms	listed	under	“Subclasses”.	You	can	explore	the	
different	subclasses	of	terms	on	HPO	using	Google.		In	this	case,	the	term	“Hypoplasia	of	dental	
enamel”	seems	to	fit	best.		
	
	
The	page	for	dental	enamel	hypoplasia	doesn’t	have	a	very	helpful	definition	so	we	had	to	
Google	dental	enamel	hypoplasia	to	get	a	better	understanding.	The	“Synonyms”	are	helpful,	so	
remember	to	look	for	those	when	you	are	trying	to	understand	the	definition	of	a	term.
	
Now	you	are	ready	to	get	started	using	the	HPO!	It	can	feel	a	bit	like	trial	and	error	when	using	
it,	especially	at	first,	but	it	does	get	easier	the	more	you	play	around	with	it.	If	you	are	feeling	
comfortable	with	the	HPO	then	check	out	the	Phenomizer	(see	below),	which	is	a	database	that	
uses	the	HPO	terms.	
PART	II:	The	Phenomizer	
	
The	Phenomizer	is	a	tool	where	you	can	enter	the	features,	signs,	and	symptoms	(the	
phenotype)	of	the	affected	person	in	your	family	to	see	if	there	are	known	diseases	that	match	
with	their	condition.	The	Phenomizer	was	designed	for	physicians	to	use	to	help	in	diagnosis,	
but	is	open	to	anyone.	That	being	said,	it	is	not	the	easiest	tool	to	navigate,	and	like	the	HPO	it	
can	take	some	time	to	get	the	hang	of	it.	To	access	the	Phenomizer	go	to	
https://compbio.charite.de/phenomizer/.		
	
				Phenomizer	uses	the	HPO	database	medical	terms	and	applies	these	to	the	diseases	that	are	
in	the	Phenomizer	database.	It	is	easiest	if	you	have	already	used	the	HPO	to	create	a	list	of	the	
medical	terms	that	apply	to	the	features	and	symptoms	of	the	affected	person.	You	can	
sometimes	search	the	Phenomizer	using	non-HPO	words	to	describe	the	disease.	The	HPO	terms	
will	sometimes	pop	up,	but	not	always,	so	it’s	easiest	if	you	already	have	them	handy.	See	the	
first	part	of	this	guide	for	tips	on	how	to	find	the	HPO	terms.	
	
	
	
	
	
	
	
	
	
You	can	also	search	the	Phenomizer	database	by	disease	name	under	the	“Diseases”	tab	if	you	
have	the	name	of	a	specific	disease	and	want	to	see	if	that	disease	is	in	the	Phenomizer	
database.		
	
If	you	aren’t	sure	of	the	medical/HPO	term	to	describe	a	symptom	you	can	try	to	find	it	under	
the	“Ontology”	tab.	This	tab	has	one	main	folder	“ORGAN	ABNORMALITY”	and	many	subfolders	
within	the	main	folder.	If	you	click	on	the	small	arrow	next	to	the	main	folder	it	will	show	you	
the	subfolders,	and	the	same	for	each	subfolder.	The	folders	are	divided	by	organ	systems	so	
you	can	search	through	the	folders	until	you	have	a	term	that	describes	the	symptom	you	are	
trying	to	describe.	This	can	be	very	time	consuming	so	it’s	recommended	that	you	try	to	find	the	
medical	terms	via	the	HPO	first.	
	
	
We	will	again	use	the	mock	patient	Anna	to	demonstrate	how	to	use	the	Phenomizer.	We	will	
enter	all	of	Anna’s	symptoms	and	unique	features	into	the	Phenomizer,	one	at	a	time.	One	of	
the	features	Anna	is	described	as	having	is	extra	thumbs,	which	we	now	know	is	called	“preaxial	
polydactly”	from	searching	the	HPO	(see	Part	1	of	this	guide).	We	will	enter	“preaxial	
polydactyly”	into	the	“Enter	feature”	bar	under	the	“Features”	tab.		
	
	
	
We	have	now	selected	“Preaxial	hand	polydactyly.	To	the	right	of	the	screen	will	be	a	list	of	all	of	
the	patient	features	once	you	add	them.	To	add	a	feature	to	the	list	on	the	right	you	have	to	
double	click	the	feature	on	the	left.		
	
	
When	you	add	a	feature	to	the	Patient’s	Features	list	the	feature	may	appear	in	the	list	under	
different	categories.	Any	broader	category	the	feature	can	fit	in	will	appear	in	the	list.	For	
example,	Preaxial	hand	polydactyly	can	fit	into	the	categories	“Abnormality	of	limbs”	and	
“Abnormality	of	the	skeletal	system”,	thus	both	appear	in	the	list.		
	
	
There	are	five	different	possible	columns	under	the	Patient’s	Features	list	and	you	can	select	
which	ones	you	would	like	to	view	or	hide.	To	select	which	columns	you	would	like	to	view	click	
on	the	arrow	next	to	“HPO”,	select	“Columns”,	and	add	a	checkmark	next	to	the	option	to	view	
it	or	remove	the	checkmark	if	you	don’t	want	to	see	that	column.	The	“Feature”	column	lists	
each	feature	added	to	the	Patient’s	Features	list.	The	“HPO”	column	lists	the	HPO	ID	number	for	
each	feature.	The	“Num	diseases”	category	lists	how	many	diseases	in	the	Phenomizer	database	
include	this	feature.	
	
You	can	continue	adding	features	by	typing	them	into	the	“Enter	feature”	bar	on	the	left	and	
double	clicking	on	the	feature.	We	have	added	all	of	Anna’s	features	and	symptoms	to	the	
Patient’s	features	list.	
	
Once	you	have	added	all	of	the	symptoms/features	to	the	Patient’s	features	list	you	can	select	
the	type	of	genetic	inheritance	pattern	you	want	to	search	for	when	searching	for	diseases.	If	
you	know	how	the	genetic	mutation	in	the	affected	individual	was	inherited	you	can	select	the	
specific	pattern;	otherwise,	select	“any”.	When	you	are	ready	to	search	for	diseases	that	fit	with	
the	list	of	features	click	on	“Get	diagnosis”	at	the	bottom	right	of	the	page.	
	
A	list	of	possible	disease	will	appear	under	the	“Diseases”	tab.	The	diseases	that	most	closely	
match	the	list	of	features	will	be	located	at	the	top	of	the	list.	The	“p-value”	is	a	word	used	in	
statistics,	and	the	lower	the	p-value	the	more	the	disease	fits	with	the	list	of	features.	In	
statistics	if	a	“p-value”	is	less	than	0.05	this	is	considered	statistically	significant	--	meaning	that	
there	is	a	high	likelihood	that	the	association	between	the	two	things	did	not	happen	by	chance.	
In	our	example	the	p-values	are	all	a	lot	higher	than	0.05,	meaning	there	isn’t	a	significant	
relationship	and	that	the	diseases	listed	don’t	match	well	with	the	list	of	Patient’s	features.	You	
can	always	explore	some	of	the	diseases	by	using	Google	to	search	for	them.	Now	you	have	the	
basics	on	how	to	use	both	the	HPO	and	the	Phenomizer.	For	more	in	depth	information	on	the	
Phenomizer,	download	the	user	manual	under	the	“Help”	tab.	Good	luck!	
	
	
